Home > Boards > US Listed > Biotechs > Chembio Diagnostics (CEMI)

Interesting stats for instys....

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
XenaLives Member Profile
Member Level 
Followed By 367
Posts 49,237
Boards Moderated 29
Alias Born 09/20/01
160x600 placeholder
Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021 GlobeNewswire Inc. - 7/22/2021 5:03:53 PM
Chembio Diagnostics gets $4M HIV test purchase order Seeking Alpha - 7/22/2021 1:03:18 PM
Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund GlobeNewswire Inc. - 7/22/2021 12:49:39 PM
NeuroMetrix stock joins Reddit-driven rally with 60% rise in Q2 revenue Seeking Alpha - 7/22/2021 10:00:48 AM
Chembio Diagnostics Bags $28.3M Oder for SARS-CoV-2 Antigen Tests from Brazil TipRanks - 7/22/2021 2:53:30 AM
Chembio surges on purchase order for COVID—19 antigen test from Brazil Seeking Alpha - 7/21/2021 8:12:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2021 6:04:51 AM
Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil GlobeNewswire Inc. - 7/20/2021 10:56:14 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/19/2021 5:29:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 5:14:54 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/12/2021 8:30:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2021 5:21:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2021 4:06:31 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/13/2021 9:27:27 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/13/2021 9:26:04 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/7/2021 6:10:06 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 5:29:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 4:30:47 PM
Chembio Diagnostics EPS beats by $0.10, beats on revenue Seeking Alpha - 5/6/2021 4:28:28 PM
Chembio Diagnostics Reports First Quarter 2021 Financial Results GlobeNewswire Inc. - 5/6/2021 4:05:00 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2021 5:04:04 PM
Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021 GlobeNewswire Inc. - 4/22/2021 8:00:00 AM
Chembio announces U.S. launch of point-of-care-test to differentiate COVID-19 and Flu Seeking Alpha - 4/5/2021 10:28:43 AM
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu GlobeNewswire Inc. - 4/1/2021 5:30:00 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 3/15/2021 6:33:37 AM
XenaLives Member Level  Friday, 10/09/20 09:15:51 AM
Re: None
Post # of 771 
Interesting stats for instys....



Institutional movement:

Current - as of 6/30/20
Quote:

Institutional Owners 167
Shares Outstanding 20,161,500 shares
Institutional Shares 11,259,410 - 55.85% (ex 13D/G)


https://fintel.io/so/us/cemi

as of 3/31/20
Quote:

Institutional Owners 74
Shares Outstanding 20,161,500 shares
Institutional Shares 9,176,062 - 45.51% (ex 13D/G)


https://fintel.io/so/us/cemi?d=2020-03-31

as of 12/19/19
Quote:
Institutional Owners 73
Shares Outstanding 20,161,500 shares
Institutional Shares 10,211,291 - 50.65% (ex 13D/G)


https://fintel.io/so/us/cemi?d=2019-12-31

as of 06/30/19
Quote:

Institutional Owners 41
Shares Outstanding 20,161,500 shares
Institutional Shares 7,520,244 - 37.30% (ex 13D/G)(ex 13D/G)



as of 12/31/18
Quote:

Institutional Owners 42
Shares Outstanding 20,161,500 shares
Institutional Shares 7,506,683 - 37.23% (ex 13D/G)



as of 06/30/18
Quote:

Institutional Owners 33
Shares Outstanding 20,161,500 shares
Institutional Shares 6,371,216 - 31.60% (ex 13D/G)




Institutions that have recently sold out completely, note that the number of institutions holding has increased dramatically but share count has remained static since 2018 or before..


2020-05-15 13F Silvercrest Asset Management Group Llc 0 -100.00 0
2020-05-15 13F Orion Portfolio Solutions, LLC 0 -100.00 0
2020-05-15 13F Meeder Asset Management Inc 0 -100.00 0
2020-05-11 13F Gagnon Securities Llc 0 -100.00 0 -100.00
2020-05-11 13F Gagnon Advisors, LLC 0 -100.00 0
2020-05-06 13F/A Russell Investments Group, Ltd. 0 -100.00 0 -100.00
2020-04-29 13F Perkins Capital Management Inc 0 -100.00 0 -100.00
2020-04-22 13F Falcon Point Capital, Llc 0 -100.00 0
2020-04-15 13F Roubaix Capital, Llc 0 -100.00 0
2020-04-13 13F Valeo Financial Advisors, Llc 0 -100.00 0
2020-02-14 13F Acuta Capital Partners, Llc 0 -100.00 0
2020-02-14 13F Marshall Wace North America L.P. 0 -100.00 0
2020-02-14 13F Squarepoint Ops LLC 0 -100.00 0
2020-02-10 13F Barclays Plc 0 -100.00 0
2020-01-09 13F Quad Capital Management Advisors LLC 0 -100.00 0 -100.00
2020-01-09 13F Mesirow Financial Investment Management, Inc. 0 -100.00 0 -100.00
2019-11-14 13F Wexford Capital Lp 0 -100.00 0 -100.00
2019-11-14 13F/A Family Management Corp 0 -100.00 0 -100.00
2019-11-14 13F Deutsche Bank Ag\ 0 -100.00 0 -100.00
2019-11-13 13F Renaissance Technologies Llc 0 -100.00 0 -100.00
2019-10-16 13F Douglas Lane & Associates, LLC 0 -100.00 0 -100.00





Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences